123 related articles for article (PubMed ID: 15624481)
1. [Gaucher disease with multiple bone necrosis treated by enzyme replacement therapy and pamidronate].
Abe M; Minoguchi M; Jinbo J; Kikuchi Y; Chiba A; Shibata Y; Kogo Y
Nihon Naika Gakkai Zasshi; 2004 Nov; 93(11):2421-3. PubMed ID: 15624481
[No Abstract] [Full Text] [Related]
2. [Osteoarticular manifestations of Gaucher disease in adults: pathophysiology and treatment].
Hachulla E; Javier RM
Rev Med Interne; 2007 Oct; 28 Suppl 2():S180-2. PubMed ID: 18228685
[No Abstract] [Full Text] [Related]
3. Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis.
Mistry PK; Deegan P; Vellodi A; Cole JA; Yeh M; Weinreb NJ
Br J Haematol; 2009 Nov; 147(4):561-70. PubMed ID: 19732054
[TBL] [Abstract][Full Text] [Related]
4. Using the International Gaucher Disease Registry data: can we devise a virtuous circle for treated patients?
Elstein D; Zimran A
Am J Hematol; 2008 Dec; 83(12):887-9. PubMed ID: 18980272
[No Abstract] [Full Text] [Related]
5. Commentary: low-dose high-frequency enzyme replacement therapy prevents fractures without complete suppression of painful bone crises in patients with severe juvenile onset type I Gaucher disease.
Elstein D; Abrahamov A; Itzchaki M; Zimran A
Blood Cells Mol Dis; 1998 Sep; 24(3):303-5; discussion 306-8. PubMed ID: 10087988
[No Abstract] [Full Text] [Related]
6. Low-dose low-frequency imiglucerase as a starting regimen of enzyme replacement therapy for patients with type I Gaucher disease.
Elstein D; Abrahamov A; Hadas-Halpern I; Meyer A; Zimran A
QJM; 1998 Jul; 91(7):483-8. PubMed ID: 9797931
[TBL] [Abstract][Full Text] [Related]
7. [Osteoarticular manifestations of Gaucher disease in adults: pathophysiology and treatment].
Javier RM; Hachulla E
Presse Med; 2007 Dec; 36(12 Pt 3):1971-84. PubMed ID: 17498916
[TBL] [Abstract][Full Text] [Related]
8. Individualization of long-term enzyme replacement therapy for Gaucher disease.
Andersson HC; Charrow J; Kaplan P; Mistry P; Pastores GM; Prakash-Cheng A; Rosenbloom BE; Scott CR; Wappner RS; Weinreb NJ;
Genet Med; 2005 Feb; 7(2):105-10. PubMed ID: 15714077
[TBL] [Abstract][Full Text] [Related]
9. Improvement of bone disease with increased dose of glucocerebrosidase in a Gaucher disease patient who had a bone lesion presenting during low-dose enzyme replacement therapy.
Ueda T; Fukunaga Y; Migita M; Watanabe A; Kaneko K; Morita T; Yamamoto M
Acta Paediatr Jpn; 1996 Jun; 38(3):260-4. PubMed ID: 8741318
[TBL] [Abstract][Full Text] [Related]
10. Progression of bone disease without deterioration of hematological parameters in a child with Gaucher disease during low-dose glucocerebrosidase therapy.
Migita M; Fukunaga Y; Ueda T; Watanabe A; Morita T; Yamamoto M
Nihon Ika Daigaku Zasshi; 1994 Nov; 61(6):633-7. PubMed ID: 7829657
[TBL] [Abstract][Full Text] [Related]
11. Taliglucerase alfa approved for Gaucher disease.
Traynor K
Am J Health Syst Pharm; 2012 Jun; 69(12):1009. PubMed ID: 22644968
[No Abstract] [Full Text] [Related]
12. Enzyme replacement in Gaucher disease.
Beutler E
PLoS Med; 2004 Nov; 1(2):e21. PubMed ID: 15578103
[TBL] [Abstract][Full Text] [Related]
13. Bone density changes with enzyme therapy for Gaucher disease.
Lebel E; Dweck A; Foldes AJ; Golowa Y; Itzchaki M; Zimran A; Elstein D
J Bone Miner Metab; 2004; 22(6):597-601. PubMed ID: 15490271
[TBL] [Abstract][Full Text] [Related]
14. Treatment regimens in Gaucher's disease.
Beutler E
Lancet; 1995 Aug; 346(8974):581-2. PubMed ID: 7658807
[No Abstract] [Full Text] [Related]
15. No price too high?
Garber AM
N Engl J Med; 1992 Dec; 327(23):1676-8. PubMed ID: 1435903
[No Abstract] [Full Text] [Related]
16. Low-dose versus high-frequency regimens in Gaucher's disease.
Maródi L
Lancet; 1995 Nov; 346(8987):1434. PubMed ID: 7475855
[No Abstract] [Full Text] [Related]
17. Ten years' experience of enzyme infusion therapy of Norrbottnian (type 3) Gaucher disease.
Erikson A; Forsberg H; Nilsson M; Aström M; Månsson JE
Acta Paediatr; 2006 Mar; 95(3):312-7. PubMed ID: 16497642
[TBL] [Abstract][Full Text] [Related]
18. Initiation treatment with imiglucerase every 3 weeks in type 1 Gaucher disease.
Serratrice C; Swiader L; Serratrice J; Weiller PJ; Verrot D
Eur J Intern Med; 2012 Mar; 23(2):e71-2. PubMed ID: 22284262
[No Abstract] [Full Text] [Related]
19. Histologic findings of femoral heads from patients with Gaucher disease treated with enzyme replacement.
Lebel E; Elstein D; Peleg A; Reinus C; Zimran A; Amir G
Am J Clin Pathol; 2013 Jul; 140(1):91-6. PubMed ID: 23765538
[TBL] [Abstract][Full Text] [Related]
20. Enzyme replacement therapy for mild patients with Gaucher disease.
Zimran A; Ilan Y; Elstein D
Am J Hematol; 2009 Apr; 84(4):202-4. PubMed ID: 19229987
[No Abstract] [Full Text] [Related]
[Next] [New Search]
